Curative Biosciences, Inc.
Curative Biosciences, Inc. (CBDX) SEC Filings & 10-K Annual Reports
SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.
SEC EDGAR · data.sec.gov · CIK 0001137005 · CBDX · OTC · as of Jun 9, 2026
Filing snapshot
Source: SEC EDGAR (data.sec.gov) · CIK 0001137005 · Updated hourly · Not investment advice
Latest Annual Report
Latest Key Filings
Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.
SEC Filing History
About SEC Filings & 10-K Annual Reports
Curative Biosciences, Inc. (OTC: CBDX) has submitted 167 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2004. As a Healthcare sector company with CIK 0001137005, all filings are publicly accessible via the EDGAR database at no cost.
The annual 10-K report is Curative Biosciences, Inc.'s most comprehensive regulatory disclosure. The most recent Curative Biosciences, Inc. 10-K was filed on 2018-04-05 for fiscal year ending 2018. Historical CBDX 10-K annual reports are available from 2001 through 2018.
Investors researching Curative Biosciences, Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.
Frequently Asked Questions
CBDX SEC Filings · 8 questionsCurative Biosciences, Inc. (CBDX) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 167 filings and access original documents at no cost. Curative Biosciences, Inc.'s CIK is 0001137005.